0001193805-11-001023.txt : 20110525 0001193805-11-001023.hdr.sgml : 20110525 20110525172056 ACCESSION NUMBER: 0001193805-11-001023 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110525 DATE AS OF CHANGE: 20110525 GROUP MEMBERS: DEERFIELD CAPITAL, L.P. GROUP MEMBERS: DEERFIELD MANAGEMENT COMPANY, L.P. GROUP MEMBERS: DEERFIELD PRIVATE DESIGN FUND, L.P. GROUP MEMBERS: DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P. GROUP MEMBERS: DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED GROUP MEMBERS: DEERFIELD SPECIAL SITUATIONS FUND, L.P. FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Flynn James E CENTRAL INDEX KEY: 0001352546 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 780 THIRD AVENUE STREET 2: 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Talon Therapeutics, Inc. CENTRAL INDEX KEY: 0001140028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320064979 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79910 FILM NUMBER: 11871881 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 370 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-588-6404 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 370 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Hana Biosciences Inc DATE OF NAME CHANGE: 20041006 FORMER COMPANY: FORMER CONFORMED NAME: EMAIL REAL ESTATE COM INC DATE OF NAME CHANGE: 20010504 SC 13D/A 1 e608512_13da-talon.htm Unassociated Document
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13D
 
[Rule 13d-101]

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 24.13d-1(a) AND AMENDMENT THERETO FILED PURSUANT TO § 240.13D-2(a)

(Amendment No. 4)*
 
TALON THERAPEUTICS, INC.
(Name of Issuer)
 
Common Stock, $0.001 par value per share
(Title of Class of Securities)
 
87484H104
(CUSIP Number)
 
 
James E. Flynn
Deerfield Capital, L.P.
780 Third Avenue, 37th Floor
New York, New York  10017
(212) 551-1600
 
With a copy to:
 
Mark I. Fisher, Esq.
Elliot Press, Esq.
Katten Muchin Rosenman LLP
575 Madison Avenue
New York, New York  10022
(212) 940-8800
  
 
 
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
May 20, 2011
(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.
 
Note:   Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.
 
(Continued on following pages)
(Page 1 of 13 Pages)
 
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 
 
 
SCHEDULE 13D
CUSIP No. 87484H104
  
Page 2 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
Deerfield Capital, L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
AF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
8,607,962 Shares (1)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
8,607,962 Shares (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,607,962 Shares (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
32.01% (2)
14
TYPE OF REPORTING PERSON
 
PN
 
(1)  Comprised of an aggregate of 2,958,062 shares of common stock, warrants to purchase 324,737 shares of common stock and  5,325,163 shares of common stock issuable as of May 24, 2011 upon the conversion of an aggregate of 39,122 shares of Series A-1 Convertible Preferred Stock held by Deerfield Special Situations Fund, L.P., Deerfield Private Design Fund, L.P. and Deerfield Private Design International, L.P.
 
(2)  Based on 21,242,772 outstanding shares of common stock of the Company as reported in the Company's Quarterly Report for the quarterly period ended March 31, 2011 filed by the Company on May 13, 2011 with the Securities and Exchange Commission.
 
 
 
 
 
SCHEDULE 13D
CUSIP No. 87484H104
  
Page 3 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
Deerfield Special Situations Fund, L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
WC
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
779,971 Shares (3)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
779,971 Shares (3)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
779,971 Shares (3)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
3.61% (4)
14
TYPE OF REPORTING PERSON*
 
PN
 
(3)    Comprised of  407,568 shares of common stock, warrants to purchase 21,415 shares of common stock and 350,988 shares of common stock issuable as of May 24, 2011 upon the conversion of 2,579 shares of Series A-1 Convertible Preferred Stock.
 
(4)   See footnote 2 above.
 
 
 
 
 
SCHEDULE 13D
CUSIP No. 87484H104
  
Page 4 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
Deerfield Private Design Fund, L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
WC
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
2,998,133 Shares (5)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
2,998,133 Shares (5)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,998,133 Shares (5)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
12.89% (6)
14
TYPE OF REPORTING PERSON*
 
PN
 
(5)  Comprised of  976,841 shares of common stock, warrants to purchase 116,172 shares of common stock and 1,905,120 shares of common stock issuable as of May 24, 2011 upon the conversion of 13,996 shares of Series A-1 Convertible Preferred Stock.
 
(6)  See footnote 2 above.
 
 
 
 
 
SCHEDULE 13D
CUSIP No. 87484H104
  
Page 5 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
Deerfield Private Design International, L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
WC
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
British Virgin Islands

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
4,829,858 Shares (7)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
4,829,858 Shares (7)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
4,829,858 Shares (7)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
19.71% (8)
14
TYPE OF REPORTING PERSON*
 
PN
 
(7)  Comprised of 1,573,653 shares of common stock, warrants to purchase 187,150 shares of common stock and 3,069,055 shares of common stock issuable as of May 24, 2011 upon the conversion of 22,546 shares of Series A-1 Convertible Preferred Stock.
 
(8)  See footnote 2 above.
 
 
 
 
 
SCHEDULE 13D
CUSIP No. 87484H104
  
Page 6 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
Deerfield Management Company, L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
AF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
1,430,744 Shares (9)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
1,430,744 Shares (9)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,430,744 Shares (9)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
6.53% (10)
14
TYPE OF REPORTING PERSON*
 
PN
 
(9)  Comprised of 747,966 shares of common stock, warrants to purchase 39,250 shares of common stock and 643,528 shares of common stock issuable as of May 24, 2011 upon the conversion of 4,728 shares of Series A-1 Convertible Preferred Stock held by Deerfield Special Situations Fund International Limited.

(10)  See footnote 2 above.
 
 
 
 
 
SCHEDULE 13D
CUSIP No. 87484H104
  
Page 7 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
Deerfield Special Situations Fund International Limited
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
WC
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
British Virgin Islands

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
1,430,744 Shares (11)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
1,430,744 Shares (11)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,430,744 Shares (11)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
6.53% (12)
14
TYPE OF REPORTING PERSON*
 
CO
 
(11)  Comprised of 747,966 shares of common stock, warrants to purchase 39,250 shares of common stock and 643,528 shares of common stock issuable as of May 24, 2011 upon the conversion of 4,728 shares of Series A-1 Convertible Preferred Stock.

(12)  See footnote 2 above.
 
 
 
 
 
SCHEDULE 13D
CUSIP No. 87484H104
  
Page 8 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
James E. Flynn
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
AF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States of America

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
10,038,706 Shares (13)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
10,038,706 Shares (13)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
10,038,706 Shares (13)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
36.40% (14)
14
TYPE OF REPORTING PERSON*
 
IN
 
(13)  Comprised of an aggregate of 3,706,028 shares of common stock, warrants to purchase 363,987 shares of common stock and 5,968,691 shares of common stock issuable as of May 24, 2011 upon the conversion of an aggregate of 43,850 shares of Series A-1 Convertible Preferred Stock held by Deerfield Special Situations Fund, L.P., Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P. and Deerfield Special Situations Fund International Limited.

(14)  See footnote 2 above.
 
 
 
 
 
CUSIP No. 87484H104
 
The Schedule 13D filed on October 19, 2009 by (i) Deerfield Capital, L.P. (“Deerfield Capital”), (ii) Deerfield Special Situations Fund, L.P. (“Deerfield Special Situations Fund”), (iii) Deerfield Private Design Fund, L.P. (“Deerfield Private Design Fund”), (iv) Deerfield Private Design International, L.P. (“Deerfield Private Design International”), (v) Deerfield Management Company, L.P. (“Deerfield Management”), (vi) Deerfield Special Situations Fund International Limited (“Deerfield Special Situations International”) and (vii) James E. Flynn, a natural person (“Flynn” and collectively with Deerfield Capital, Deerfield Special Situations Fund, Deerfield Private Design Fund, Deerfield Private Design International, Deerfield Management and Deerfield Special Situations International, the “Reporting Persons”), as amended by Amendment No. 1 filed on June 11, 2010, Amendment No. 2 filed on September 16, 2010, Amendment No. 3 filed on February 4, 2011, with respect to the securities of Talon Therapeutics, Inc. (formerly Hana Biosciences, Inc.) is hereby amended by this Amendment No. 4. Only those items hereby reported in this Amendment No. 4 are amended and all other items remain unchanged.  Terms used herein but not otherwise defined herein shall have the meanings ascribed thereto in Amendment No.1 to the Schedule 13D.

Item 5.                    Interest in Securities of the Issuer.

Items 5(a), 5(b) and 5(c) of the Schedule 13D are amended and restated to read as follows:

All of the computations and share amounts used here do not give effect to any accretion of shares Series A-1 Preferred Stock after May 24, 2011.

(a)

(1)           Reporting Persons

Number of shares: 10,038,706 (13)
Percentage of shares: 36.40% (2)

(2)           Deerfield Capital

Number of shares: 8,607,962 (1)
Percentage of shares: 32.01% (2)

(3)           Deerfield Special Situations Fund

Number of shares: 779,971 (3)
Percentage of shares: 3.61% (2)

(4)           Deerfield Private Design Fund

Number of shares: 2,998,133(5)
Percentage of shares: 12.89% (2)
 
 
 
 
 
CUSIP No. 87484H104
 
(5)           Deerfield Private Design International

Number of shares: 4,829,858(7)
Percentage of shares: 19.71% (2)

 (6)           Deerfield Management

Number of shares: 1,430,744 (9)
Percentage of shares: 6.53% (2)

(7)           Deerfield Special Situations International

Number of shares: 1,430,744 (11)
Percentage of shares: 6.53% (2)

(8)           Flynn

Number of shares: 10,038,706 (13)
Percentage of shares: 36.40% (2)

(b)

(1)           Deerfield Capital

Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:   8,607,962 shares (1)
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:   8,607,962 shares (1)

(2)           Deerfield Special Situations Fund

Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  779,971 shares (3)
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  779,971 shares (3)
 
(3)           Deerfield Private Design Fund

Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  2,998,133 shares (5)
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  2,998,133 shares (5)
 
(4)           Deerfield Private Design International

Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  4,829,858 shares (7)
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  4,829,858 shares (7)
 
 
 
 
 
CUSIP No. 87484H104
 
(5)           Deerfield Management

Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  1,430,744 shares (9)
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  1,430,744 (9)

(6)           Deerfield Special Situations International

Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  1,430,744 (11)
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  1,430,744 shares (11)

(7)           Flynn

Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  10,038,706 shares (13)
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  10,038,706 shares (13)

Flynn is the sole member of the general partner of each of Deerfield Capital and Deerfield Management.  Deerfield Capital is the general partner of Deerfield Special Situations Fund, Deerfield Private Design Fund and Deerfield Private Design International.  Deerfield Management is the investment manager of Deerfield Special Situations International.

(c)              The following table sets forth the transactions effected by the Reporting Persons in the shares of Common Stock of the Company during the 60 days prior to the date of filing of this Schedule 13D.  All transactions listed below were effected as open market sales. 

Date
Seller
Number of Shares of Common Stock Sold
 
Price
May 17, 2011
Deerfield Special Situations Fund, L.P.
18,489
$1.12
May 17, 2011
Deerfield Special Situations Fund International Limited
28,919
$1.12
May 17, 2011
Deerfield Private Design Fund, L.P.
46,501
$1.12
May 17, 2011
Deerfield Private Design International, L.P.
74,913
$1.12
May 18, 2011
Deerfield Special Situations Fund, L.P.
8,406
$1.11
May 18, 2011
Deerfield Special Situations Fund International Limited
13,149
$1.11
May 18, 2011
Deerfield Private Design Fund, L.P.
21,143
$1.11
 
 
 
 
 
CUSIP No. 87484H104
 
May 18, 2011
Deerfield Private Design International, L.P.
34,061
$1.11
May 19, 2011
Deerfield Special Situations Fund, L.P.
5,698
$1.11
May 19, 2011
Deerfield Special Situations Fund International Limited
8,915
$1.11
May 19, 2011
Deerfield Private Design Fund, L.P.
14,334
$1.11
May 19, 2011
Deerfield Private Design International, L.P.
23,092
$1.11
May 20, 2011
Deerfield Special Situations Fund, L.P.
5,365
$0.99
May 20, 2011
Deerfield Special Situations Fund International Limited
8,394
$0.99
May 20, 2011
Deerfield Private Design Fund, L.P.
7,547
$1.00
May 20, 2011
Deerfield Private Design International, L.P.
12,159
$1.00
May 20, 2011
Deerfield Special Situations Fund, L.P.
3,000
$1.00
May 20, 2011
Deerfield Special Situations Fund International Limited
4,694
$1.00
May 20, 2011
Deerfield Private Design Fund, L.P.
13,495
$0.99
May 20, 2011
Deerfield Private Design International, L.P.
21,741
$0.99
May 23, 2011
Deerfield Special Situations Fund, L.P.
1,774
$1.00
May 23, 2011
Deerfield Special Situations Fund International Limited
2,777
$1.00
May 23, 2011
Deerfield Private Design Fund, L.P.
4,464
$1.00
May 23, 2011
Deerfield Private Design International, L.P.
7,192
$1.00
May 24, 2011
Deerfield Special Situations Fund, L.P.
30,779
$1.00
May 24, 2011
Deerfield Special Situations Fund International Limited
48,135
$1.00
May 24, 2011
Deerfield Private Design Fund, L.P.
77,399
$1.00
May 24, 2011
Deerfield Private Design International, L.P.
124,688
$1.00
 
 
 
 
 
CUSIP No. 87484H104
 
SIGNATURE

After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated:  May 25, 2011
 
 
DEERFIELD CAPITAL, L.P.
       
 
By: 
 J.E. Flynn Capital LLC, General Partner  
       
 
By: 
 /s/ Darren Levine  
 
Name: 
 Darren Levine  
 
Title:
Attorney-in-Fact*
  

 
DEERFIELD SPECIAL SITUATIONS FUND, L.P.
       
 
By: 
 Deerfield Capital, L.P., General Partner  
       
 
By: 
 J.E. Flynn Capital LLC, General Partner  
       
 
By: 
 /s/ Darren Levine  
 
Name: 
 Darren Levine  
 
Title:
Attorney-in-Fact*
  
 
 
DEERFIELD PRIVATE DESIGN FUND, L.P.
       
 
By: 
 Deerfield Capital, L.P., General Partner  
       
 
By: 
 J.E. Flynn Capital LLC, General Partner  
       
 
By: 
 /s/ Darren Levine  
 
Name: 
 Darren Levine  
 
Title:
Attorney-in-Fact*
  
 
 
DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.
       
 
By: 
 Deerfield Capital, L.P., General Partner  
       
 
By: 
 J.E. Flynn Capital LLC, General Partner  
       
 
By: 
 /s/ Darren Levine  
 
Name: 
 Darren Levine  
 
Title:
Attorney-in-Fact*
  
 
 
DEERFIELD MANAGEMENT COMPANY, L.P.
       
 
By: 
 Flynn Management LLC, General Partner  
       
 
By: 
 /s/ Darren Levine  
 
Name: 
 Darren Levine  
 
Title:
Attorney-in-Fact*
  

 
DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED
  
       
 
By: 
 /s/ Darren Levine  
 
Name: 
 Darren Levine  
 
Title:
Attorney-in-Fact*
  
       
 
JAMES E. FLYNN
  
       
 
/s/ Darren Levine
  
 
Darren Levine, Attorney-in-Fact*
  
  
*Power of Attorney previously filed as Exhibit 99.3 to a Schedule 13D/A with regard to Hana Biosciences, Inc. (now known as Talon Therapeutics, Inc.) filed with the Securities and Exchange Commission on June 11, 2010 by Deerfield Capital L.P.; Deerfield Management Company, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Special Situations Fund International Limited; Deerfield Private Design Fund, L.P.; Deerfield Private Design International, L.P. and James E. Flynn.